Motivation

The Pfizer mRNA “vaccine” trial 2-month data report “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”, claimed 95% EFFICACY on the basis of RRR (relative risk reduction) in only 170 trial participants out of the total of 43,448 who received injections. This deep dive investigative article finds serious protocol violations in those crucial 170 participants, i.e. invalidating the 95% EFFICACY claim.

Author

Jeyanthi Kunadhasan

Submitted By

Dr Herman Edeling

Supported By

Dr Stephen Schmidt

Type of Article

News, The Spectator Australia